Moon, C. (2021). Northern Territory Drug Trends 2020: Key findings from the Illicit Drug Reporting System (IDRS) Interviews [10.26190/13n8-4f41](978-0-7334-3970-4). https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/IDRS_NT_2020_Final.pdf

Morphett, K., et al., Attitudes towards a hypothetical ‘clean nicotine’ product and harm reduction among smokers. International Journal of Drug Policy, 2021. 88.

Morphett, K., Puljević, C., Borland, R., Carter, A., Hall, W., & Gartner, C. (2021). Attitudes towards a hypothetical ‘clean nicotine’ product and harm reduction among smokers [10.1016/j.drugpo.2020.103020]. International Journal of Drug Policy, 88. https://doi.org/10.1016/j.drugpo.2020.103020

Mulchandani, R., Brown, B., Brooks, T., Semper, A., Machin, N., Linley, E., Borrow, R., Wyllie, D., Taylor-Philips, S., Jones, H., Oliver, I., Charlett, A., & Hickman, M. (2021). Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay [10.1016/j.jcv.2021.104739]. Journal of Clinical Virology, 136. https://doi.org/10.1016/j.jcv.2021.104739

Munn-Chernoff, M. A., Johnson, E. C., Chou, Y. L., Coleman, J. R. I., Thornton, L. M., Walters, R. K., Yilmaz, Z., Baker, J. H., Hübel, C., Gordon, S., Medland, S. E., Watson, H. J., Gaspar, H. A., Bryois, J., Hinney, A., Leppä, V. M., Mattheisen, M., Ripke, S., Yao, S., . . . La Via, M. C. (2021). Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies [10.1111/adb.12880]. Addiction Biology, 26(1). https://doi.org/10.1111/adb.12880

Najman, J. M., Clare, P. J., Kypri, K., Aiken, A., Wadolowski, M., Hutchinson, D., Slade, T., Bruno, R., Vogl, L., Degenhardt, L., & Mattick, R. P. (2021). Gender differences in the supply of alcohol to adolescent daughters and sons [10.1080/00952990.2021.1927066]. American Journal of Drug and Alcohol Abuse, 47(4), 508-520. https://doi.org/10.1080/00952990.2021.1927066

Neupane, D., Levis, B., Bhandari, P. M., Thombs, B. D., Benedetti, A., Sun, Y., He, C., Wu, Y., Krishnan, A., Negeri, Z., Imran, M., Rice, D. B., Riehm, K. E., Saadat, N., Azar, M., Sanchez, T. A., Chiovitti, M. J., Levis, A. W., Boruff, J. T., . . . Yamada, M. (2021). Selective cutoff reporting in studies of the accuracy of the Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale: Comparison of results based on published cutoffs versus all cutoffs using individual participant data meta-analysis [10.1002/mpr.1873]. International Journal of Methods in Psychiatric Research, 30(3). https://doi.org/10.1002/mpr.1873

Ney, L. J., Felmingham, K. L., Bruno, R., Matthews, A., & Nichols, D. S. (2021). Chloroform-based liquid-liquid extraction and LC–MS/MS quantification of endocannabinoids, cortisol and progesterone in human hair [10.1016/j.jpba.2021.114103]. Journal of Pharmaceutical and Biomedical Analysis, 201. https://doi.org/10.1016/j.jpba.2021.114103

Ney, L., et al., Endocannabinoid reactivity to acute stress: Investigation of the relationship between salivary and plasma levels. Biological Psychology, 2021. 159.

Nielsen, S., & Olsen, A. (2021). Using the behaviour change wheel to understand and address barriers to pharmacy naloxone supply in Australia [10.1016/j.drugpo.2020.103061]. International Journal of Drug Policy, 90. https://doi.org/10.1016/j.drugpo.2020.103061

Nielsen, S., Gisev, N., Leung, J., Clare, P., Bruno, R., Lintzeris, N., Larance, B., Blyth, F., Hall, W., Cohen, M., Degenhardt, L., Farrell, M., & Campbell, G. (2021). Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study [10.1111/bcp.14715]. British Journal of Clinical Pharmacology, 87(8), 3092-3104. https://doi.org/10.1111/bcp.14715